Stay updated on Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial page.

Latest updates to the Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.5.3 was added, replacing the previous v3.5.2. This indicates a small update to the page's documentation or UI.SummaryDifference0.0%

- Check22 days agoChange DetectedRevision: v3.5.2 was added, replacing the previous v3.5.0.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision tag in the page footer updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check72 days agoChange DetectedCordaleo, Turkey (Türkiye) was added as a participating site and Karşıyaka, Turkey (Türkiye) was removed from the participating locations.SummaryDifference0.2%

- Check87 days agoChange DetectedThe page adds the keyword 'Gastric cancer', introduces the Genetic and Rare Diseases Information Center as a resource, and updates the site revision from v3.4.1 to v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial page.